Drugs | The Knowledge Dynasty

Drugs

Why we should de-criminalize all drugs | Maia Szalavitz

It’s impossible to remove the stigma of addiction; while drug use remains illegal the two concepts are completely at odds with one another.

Across the political spectrum, politicians, law enforcement officials and even many activists are surprisingly united in the belief that addiction is a disease. We need to reduce associated stigma, they intone; we cant arrest our way out of the drug problem. Massachusetts is even running a media campaign called State without Stigma to try to get people to see addiction as illness, not evil.

However, in a country in which the most common reason for being arrested is drug offenses (overwhelmingly, marijuana possession) and which spends tens of billions of dollars on policing and incarcerating drug offenders, these well-intended efforts dont stand a chance.

We can either criminalize drug possession or fight stigma: we cant do both at once any more than one runner can sprint in opposite directions at the same time. The whole point of criminalizing drug use is to stigmatize drug users.

Consider why particular acts are seen as crimes in the first place. Behaviors are made illegal because they are seen as harmful or antisocial; the main idea is to deter people from engaging in them by using the law to draw a line. The law says: these actions are socially unacceptable, and anyone who violates them deserves shame, punishment, rejection and moral condemnation.

To argue that addiction is a disease while criminalizing possession of the drug involved in the addiction is, then, to make an impossible case. You are saying I think your addiction is shameful and users of the drugs you take should be caged, while also claiming You have an illness that should be treated like any other disease. Neither cancer patients, nor people with diabetes nor those with depression are put into this double bind: no actual disease is seen this way.

Add to this the fact that the treatment given to people with addiction unlike treatment for any other disorder, mental or physical is also heavily moralistic, typically involving prayer, confession and restitution and frequently including deliberate humiliation of a type that is, again, not seen anywhere else in medicine. For example, was there ever a mainstream cardiac rehabilitation program that involved dressing patients who broke rules in drag or diapers? Until at least the late 1990s, such treatment was common in addiction programs and deliberately derisive counseling remains so. This, obviously, perpetuates stigma.

Consider, too, the issue of drug courts in which the defendants medical treatment for addiction is determined by prosecutors and a judge, not by doctors. Punishment for relapse is seen as an acceptable part of the process, something that doesnt happen in diabetes care or high blood pressure treatment. Worse, more than half of these courts restrict or entirely reject use of maintenance treatment with methadone or buprenorphine for opioid addictions even though maintenance is both the standard of care and the only treatment that is known to save lives by reducing mortality 50% or more compared to other programs. (Although the Obama administration is trying to change this by refusing to fund courts that dont offer maintenance, many courts rely on state rather than federal funding.)

Importantly, in courts that deal with mentally ill defendants, there is no similar meddling. Because it is not a crime to be mentally ill, judges recognize that the expertise needed to cope with the issue is medical, not moral, and they defer to psychiatrists about what treatment and medications are best. With addiction, since drug possession is a crime, judges feel as though their expertise is whats needed to stop it.

Of course, its not wrong to want to try to end stigma: all of the politicians and advocates are right that stigma and associated shame are a huge part of why people dont seek addiction help and of why the help on offer is not particularly effective or even available. If we want better drug policy, fighting addiction stigma is a crucial goal.

The methods advocates have suggested, however, are far too weak. Yes, as Massachusetts State without Stigma suggests, we can make some progress by doing things like eliminating demeaning language. People with addiction shouldnt be called addicts in the same way that people with schizophrenia shouldnt be called schizophrenics; person-first language recognizes our common humanity.

Further, being drug free shouldnt be called clean, with the implication that active addiction is dirty. And terms like substance abuser have been shown to make even medical professionals more likely to see punitive approaches as acceptable: better language is substance use disorder or addiction. Language matters.

But actions matter more. If we really want to treat addiction like the medical problem it so clearly is, we cant use the criminal justice system to arrest people for showing symptoms of it. If you want to fight stigma, youve got to first fight criminalization and reform the coercive and demeaning addiction treatment system that has been warped by it.

Read more: https://www.theguardian.com/us-news/commentisfree/2016/jul/05/why-de-criminalize-all-drugs-stigma

Reduction of effective dose of statins, by liver targeting delivery, could be a way to bring the drugs to the prevention market – proof-of-concept trial by Lycotec Ltd.


Statins are one of the most successful drugs able to slow down the formation of cholesterol-rich atherosclerotic plaques on the arterial walls, and reduce the development of and mortality from coronary heart disease, CHD.

Although their efficacy in management of elevated LDL cholesterol and CHD is not questionable, recommendation of their use for preventative purposes for healthy people or even borderline conditions is a subject of an ongoing strong debate.

Statins like many other drugs have their own side-effects. The use of them for people with elevated cholesterol or with already established CHD overpowers these side-effects. However, the use of statins for preventative purposes with possibilities to develop, albeit not too frequent, but still negative reactions, remains controversial.

The main reason behind the side-effects is the distribution and accumulation of statins outside their main target, the liver, into skeletal muscles or other organs.

Lycotec Ltd., the Cambridge UK based biotech company has developed and patented liver targeting oral delivery technology, LycosomeTM – http://www.lycotec.com

Based on this technology, the company has created a prototype, LycoStatinTM.

In a double blind study 40 volunteers with elevated LDL cholesterol were randomised and distributed in 5 groups with 8 participants each. The first three groups received daily either 20, or 40 or 80 mg of Simvastatin. The fourth group received LycoStatinTM containing 20 mg of Simvastatin. and the fifth group received a control lycopene, the carotenoid with is used to make Lycosomes, in the same dose as in the fourth group.

After one month of the trial it was shown that the level of the reduction of LDL cholesterol in the fourth group was significantly stronger than in the groups taking 20 or 40 mg of Simvastatin, and was at the same level as in the group which was taking 80 mg of the drug. There were no changes in LDL level in the fifth group.

These preliminary results indicate that the liver targeting delivery could increase the efficacy of statins, by apparent reduction of their random distribution to other organs, which are not involved in LDL synthesis, hence potentially minimise the side-effects of these drugs.

Some results of this trial have now been published in a peer review journal as a State of the Art Paper: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4424257/pdf/AMS-11-25022.pdf

Later this week the Lycotec team, Dr Ivan Petyaev and Dr Yuiry Bashmakov, will present the LycoStatinTM at the World Liver Targeting Conference in Malta: http://www.targeting-liver.com

The company believes that reducing the effective dose of statins, minimising their potential side-effects, would allow these drugs, which have already saved millions of lives of people with CHD, to expand their benefit to even more millions of healthy people to prevent the development of this dominating killer disease in the developed world.

Lycotec is now looking for pharmaceutical industry partnership to further develop LycoStatin and bring it, and its potential range, to the CHD preventative market.







Related Technology Press Releases

Medicationdiscountcard.com Encourages Men to Prioritize Health and Wellness, Offers Coupons on Leading Prescription Drugs


New York, NY (PRWEB) June 04, 2015

June is officially Men’s Health Month, when men across the nation are encouraged to get physical exams and generally take better care of themselves. Many of the most common health issues among middle-aged and older men are preventable with the right screenings or treatable with prescription medications. To help men save money at the pharmacy, Medicationdiscountcard.com offers discount cards on all of the most frequently prescribed drugs for men.

Flomax

As men age, the prostate naturally grows larger, which inevitably leads to more frequent bathroom breaks. When frequent or painful urination is an issue, men should consult with their doctor, who will perform tests to distinguish between a natural, benign prostate enlargement and something more serious like prostate cancer. In the case of benign enlargement, Flomax works by relaxing muscles in and around the prostate. Men with enlarged prostates can print a Flomax coupon from Medicationdiscountcard.com today and save money immediately.

Plavix

Cardiovascular disease – a general term for a range of conditions – is the leading cause of death among both men and women, though men tend to develop the disease earlier than women do. Prevention is the best cure of course, but proper treatment during and after a heart attack or stroke can help men lead a full, normal life. Among those treatments is Plavix, a popular and effective tool in preventing blood clots before they happen. Medicationdiscountcard.com provides a free Plavix coupon for use by anyone with a doctor’s prescription.

Lipitor

High LDL cholesterol is a major risk factor in stroke, heart attack and associated conditions, but these risks can be headed off at the pass. Men in their 40s should have blood testing performed about every two years; past 50, they should schedule an annual test. When blood screen results show numbers creeping into the “bad” range, Lipitor can bring these under control. Anyone taking medication for cholesterol should also begin making better lifestyle choices, such as reducing high-fat foods and getting more exercise. A long-term prescription is much more affordable with a Lipitor coupon from Medicationdiscountcard.com.

Viagra and Cialis

Viagra wrote its name into the history books when it was introduced more than 10 years ago. The blockbuster drug even helped earn its creator, Dr. Robert Furchgott, a Nobel Prize in Physiology and Medicine. Despite its market success, Viagra was not 100% effective for everyone – a small percentage of men were still frustrated. Enter Cialis, a more recent erectile dysfunction (ED) drug that has worked well in cases where other drugs like Viagra have failed. Cialis quickly became the second bestselling ED prescription medication in the world. Viagra and Cialis coupons are both available from Medicationdiscountdard.com

Note: The information above is intended to supplement, not substitute for, the expertise and judgment of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that use of the drug is safe, appropriate, or effective for you. Consult your healthcare professional before using this drug.

About Medicationdiscountcard.com

Medicationdiscountcard.com was started to provide discounts on prescription drugs to those who need it most. Our goal is to provide you with the largest savings possible when compared to other cards. We invite you to compare the savings our card will provide to that of other leading providers.






Related Medicine Press Releases

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Categories

Coursera

New Skills, New You: Transform your career in 2016 with Coursera

Follow us on Twitter